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Summary			Neuroprosthetic	rehabilitation	demonstrated	that	significant	functional	benefit	could	be	achieved	with	lumbosacral	neuromodulation	in	both	human	and	animal	models	of	spinal	cord	 injury.	 It	 promoted	 the	 recovery	 of	 voluntary	 leg	 movements	 through	 the	reorganization	 of	 residual	 reticulospinal	 and	 propriospinal	 projections	 pathways.	However,	in	case	of	complete	spinal	cord	injuries	(SCI),	which	isolate	the	circuits	under	the	lesion	from	any	supraspinal	control,	the	outcome	of	neuroprosthetic	rehabilitation	is	still	 not	 sufficient.	 Indeed,	 it	 will	 require	 the	 restoration	 of	 robust	 regrowth	 and	sprouting	of	several	types	of	axons	across	the	injury.	Axons	fail	to	regrow	across	spinal	lesions	because	of	different	 inhibitory	mechanisms.	 It	has	been	demonstrated	that	this	spontaneous	 axon	 regeneration	 failure	 can	be	 reversed	by	 i)	 stimulating	 the	neuronal	intrinsic	 growth	 capacity	 using	 viral	 technology,	 ii)	 remodeling	 the	 lesion	 core	 with	growth	factors,	in	order	to	create	a	more	permissive	environment,	and	iii)	guiding	axons	with	 chemo-attractive	 molecules	 across	 and	 beyond	 the	 SCI	 site.	 It	 was	 thus	demonstrated	 that	 propriospinal	 axons	 are	 able	 to	 regrow	 and	 build	 a	 robust	descending	 bridge	 across	 complete	 SCIs	 when	 the	 needed	 facilitators	 are	 provided.	However,	 this	 robust	 propriospinal	 bridging	 failed	 to	 promote	 functional	 recovery	 by	itself.	 It	 might	 be	 explained	 by	 an	 insufficient	 descending	 motor	 control	 partly	supported	by	other	systems	such	as	the	reticulospinal	tract	(RtST)	and	the	corticospinal	tract	 (CST).	 Therefore	we	wanted	 to	 study	 the	 regenerative	 potential	 of	 the	RtST	 and	CST	 pathways.	 The	 RtST	 arises	 from	 the	 brainstem	 and	 reaches	 for	 the	 spinal	 cord	acting	as	relay	for	descending	motor	cortical	commands.	The	CST	is	the	main	descending	motor	cortical	command	arising	from	the	primary	motor	cortex.		In	the	present	study,	we	applied	the	same	strategy	to	enhance	sprouting	and	regrowth	of	 reticulospinal	 and	 corticospinal	neurons	across	 anatomically	 complete	 SCI.	We	 first	activated	 the	 neuronal	 intrinsic	 growth	 capacity	 of	 both	 tracts	 using	 viral	 technology.	The	 lesion	 environment	 was	 then	 remodeled	 with	 growth	 factors,	 delivered	 using	 a	biocompatible	 hydrogel.	 Finally,	we	 established	 chemical	 axon	 guidance	 using	 chemo-attractant	molecules.	These	interventions	were	delivered	with	a	spatiotemporal	profile	corresponding	to	the	axon	growth	sequence	during	development.	We	did	not	obtain	any	CST	 regeneration,	 due	 to	 the	 severe	 crush	 injury	model	 inducing	 extensive	CST	 axons	degeneration	 probably	 caused	 by	 ischemic	 phenomenon.	 Regarding	 the	 RtST,	 we	obtained	 significant	 reticulospinal	 regeneration	 into	 the	 lesion	 core	 with	 some	 fibers	growing	 across	 the	 lesion	 reaching	 the	 healthy	 caudal	 tissue.	 This	 regeneration	remained	 limited	 though	 as	 compared	 with	 the	 propriospinal	 results	 indicating	 the	importance	 of	 identifying	 complementary	 strategies	 to	 increase	 the	 density	 of	 the	regenerated	 tract	 and	 to	 attract	 the	 axons	 in	 the	 healthy	 tissue	 below	 the	 SCI.	 Our	ultimate	goal	is	to	restore	anatomical	communications	across	complete	SCI	and	promote	their	functional	integration	using	neuroprosthetic	rehabilitation	program.	
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Introduction		According	to	the	World	Health	Organization	between	250’000	and	500’000	people	are	affected	by	spinal	cord	injury	(SCI)	each	year	worldwide.	Traffic	accidents	and	falls	are	the	primary	causes	of	SCI	and	the	age	of	peak	incidence	is	typically	between	15	and	30	years	 with	 a	 greater	 percentage	 of	 males	 than	 females	 (Singh,	 Tetreault,	 Kalsi-Ryan,	Nouri,	&	Fehlings,	2014).	Spinal	cord	injuries	result	in	a	disruption	of	the	normal	motor,	sensory	and	autonomic	functions	below	the	lesion.	The	neurological	deficits	depend	on	the	 location	 and	 the	 extent	 of	 the	 lesion	 and	 can	 vary	 from	mild	 sensitive	 and	motor	defects,	 bladder	 and	bowel	 dysfunction	 to	 tetraplegia.	Depending	 on	 the	 extent	 of	 the	lesion,	 the	SCI	 can	be	either	 complete	or	 incomplete	 and	 is	 classified	according	 to	 the	ASIA	impairment	scale	published	by	the	American	Spinal	Injury	Association	(1982)	and	revised	in	2011	(Kirshblum	et	al.,	2011).	Most	of	the	time,	the	spinal	cord	is	compressed	leaving	 some	 neurological	 tissue	 intact.	 SCIs	 result	 in	 chronic	 neurological	 defects	associated	with	a	decrease	of	autonomy,	life	expectancy	and	social	well-being	leading	to	a	 drastic	 decrease	 of	 the	 quality	 of	 life.	 The	 management	 of	 SCI	 requires	 significant	amount	 of	 health	 care	 resources	 and	 is	 associated	 with	 considerable	 costs	 for	 the	patients,	 their	 families	and	society	 (Singh	et	al.,	2014).	The	actual	 care	 relies	on	acute	surgical	decompression	and	stabilization	of	the	spinal	cord,	prevention	of	the	secondary	damages	 and	 neurorehabilitation	 (Mothe	 &	 Tator,	 2012).	 Incomplete	 injuries	 spare	some	 functional	 tissue	 across	 and	 around	 the	 lesion	 allowing	 spontaneous	reorganization	 of	 circuits	 associated	 with	 partial	 recovery	 of	 function.	 Activity-based	therapy,	which	attempts	 to	 reactivate	muscles	below	 the	 injury,	has	 shown	significant	improvement	of	neurological	 functions	 and	 leads	 to	walking	 recovery	 in	 some	patient	with	incomplete	motor	spinal	cord	injury	(Behrman,	Ardolino,	&	Harkema,	2017;	Jones	et	al.,	2014).	Recently,	 it	was	reported	that	epidural	spinal	cord	stimulation	associated	with	 intense	 locomotor	 training	 in	 standing	 and	 stepping	 allowed	 the	 recovery	 of	intentional	 walking	 over	 ground	 in	 patient	 with	 chronic	 motor	 complete	 paralysis	(Angeli	 et	 al.,	 2018;	 Rejc,	 Angeli,	 Atkinson,	 &	 Harkema,	 2017).	 In	 addition,	 it	 was	demonstrated	 that	 epidural	 electrical	 stimulation	 (EES)	 delivered	 in	 a	 spatiotemporal	manner	 associated	 with	 intense	 over	 ground	 locomotor	 training	 enabled	 restoring	voluntary	 control	 of	 walking	 in	 patients	 with	 complete	 spinal	 cord	 paralysis.	 The	functional	 improvement	 was	 persistent	 over	 time	 even	 without	 EES	 (Wagner	 et	 al.,	2018).	In	these	approaches	the	recovery	is	supported	by	spared	fibers	within	the	spinal	cord.	 In	 case	of	 complete	SCI,	 in	which	all	 the	 connections	are	 lost,	 recovery	 is	hardly	conceivable	 without	 restoring	 some	 descending	 pathways	 such	 as	 the	 Corticospinal	tract	 (CST),	 the	 Reticulospinal	 tract	 (RtST)	 and	 the	 Propriospinal	 system	 (PrSp).	However,	 the	 spontaneous	 axons	 regrowth	 ability	 within	 the	 adult	 central	 nervous	system	 (SNC)	 is	 quite	 limited.	 Potential	 mechanisms	 include	 a	 low	 intrinsic	 growth	capacity	of	mature	CNS	neurons,	 the	presence	of	external	 inhibitory	 factors	associated	with	 fibrotic	 tissue	 or	 myelin	 and	 the	 absence	 of	 external	 growth	 stimulation	 and	environmental	 supportive	 cues	 (Anderson	 et	 al.,	 2016).	 Several	 strategies	 are	 being	investigated,	 but	 restoring	 motor	 function	 after	 complete	 SCI	 remains	 to	 this	 date	 a	
		 				challenge.	 Our	 objective	 is	 to	 induce	 axon	 regrowth	 throughout	 complete	 lesions,	 in	order	to	support	the	establishment	of	new	synapses	with	coherent	targets	and	restore	organized	 descending	 circuitry	 needed	 for	 functional	 recovery.	 For	 this	 purpose,	 it	 is	necessary	to	create	a	more	permissive	lesion	environment,	increasing	the	regeneration	capacity	of	 the	 injured	axons	as	well	as	attracting	them	across	the	 lesion	 into	targeted	networks	below	the	injury.		
Descending	motor	pathways	Voluntary	 movement	 involves	 numerous	 brain	 regions	 interacting	 as	 a	 circuit	 to	generate	motor	 commands.	Different	descending	motor	pathways	 further	process	 and	conduct	these	signals	for	the	creation	a	purposeful	movement.		Roger	Lemon	described	in	 2008	 these	 descending	 pathways	 base	 on	 the	 work	 of	 Hans	 Kuypers.	 They	 are	composed	 of	 i)	 brainstem	 pathways,	 ii)	 the	 “emotional	 motor	 system”,	 iii)	 the	Corticospinal	and	the	Corticobulbar	pathways”.		The	ventromedial	brainstem	pathways	are	 composed	of	 the	 tectospinal	 and	 the	vestibulospinal	 systems,	 as	 the	 reticulospinal	and	 bulbospinal	 projections	 arising	 from	 the	 pontomedullary	 reticular	 formation	(PMRF).	 These	 tracts	 reach	 for	 the	 ventromedial	 part	 of	 the	 intermediate	 zone	 (IZ),	 a	white	matter	structure	located	between	the	grey	dorsal	and	ventral	horns	in	the	spinal	cord.	 The	 reticulospinal	 system,	 arising	 mainly	 from	 the	 gigantocellular	 reticular	nucleus,	 is	 involved	 in	 the	control	of	proximal	synergies	 in	 the	 forelimb	and	hindlimb,	and	 gates	 postural	 changes	 required	 for	 locomotion.	 The	 dorsolateral	 brainstem	pathways	regroup	the	rubrospinal	tract	and	the	pontospinal	tract,	both	projecting	to	the	dorsal	part	of	the	IZ	and	control	short	propriospinal	neurons.	The	“emotional	system”	is	composed	 of	 a	 number	 of	 serotoninergic	 (5-HT)	 and	 noradrenergic	 (NA)	 projections	that	 further	 influence	 movement	 in	 the	 spinal	 cord	 (e.g.	 5-HT	 influences	 the	 spinal	reflexes).	 The	 corticospinal	 (CST)	 and	 corticobulbar	 (CB)	 pathways	 regroup	 axons	arising	from	different	cortical	regions	(mainly	motor	areas)	that	innervate	all	regions	of	the	 spinal	 gray	 matter	 including	 motor	 neurons	 (MN)	 at	 all	 levels	 of	 the	 spinal	 cord	(CST)	and	the	brain	stem	(CB).	It	has	been	shown	that	direct	corticomotoneuronal	(CM)	projections	are	only	present	in	primate	and	support	the	fine	manual	dexterity	required	for	 prehensile	 purpose.	 In	 rodent,	 the	 information	 transmitted	 from	 the	 CST	 to	 the	motoneurons	 is	made	via	 interneurons	and	 reticulospinal	neurons.	 In	 these	 species,	 it	seems	that	the	reticulospinal	control	of	movement	exerts	a	high	relevance	(Alstermark	&	Ogawa,	2004;	Lemon,	2008;	Lemon	&	Griffiths,	2005)	(fig.1).		
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Fig.	 1.	 Schematic	 representation	of	 the	descending	pathways.	The	 corticospinal	 tract	 reaching	 for	motoneurons	 in	 the	ventral	 horn	 (blue).	 The	 corticobulbar	 tract	 reaching	 for	 the	 brainstem	 (in	 black).	 The	 ventral	 brainstem	 pathways,	encompassing	 the	 reticulospinal,	 tectospinal	 and	 vestibulospinal	 tracts	 (green).	 	 The	 dorsolateral	 brainstem	 pathway,	(the	rubrospinal,	in	red).		The	intermediate	zone	(IZ)	is	represented	in	red.			In	addition	to	long	descending	motor	pathways,	propriospinal	neurons	(PSNs)	are	know	to	link	different	spinal	segments,	coordinate	spinal	activity	and	support	both	excitatory	and	 inhibitory	 on	motor	 neurons.	 In	 addition	 they	 project	 to	 lateral	 reticular	 nucleus	neurons	 and	 spinocerebellar	 neurons	 giving	 information	 to	 the	 cerebellum	 about	 the	upcoming	command	signal	(Alstermark,	Isa,	Pettersson,	&	Sasaki,	2007).	Different	types	of	 PSNs	 have	 been	 described;	 the	 so-called	 long	 PSNs	 and	 short	 PSNs.	 The	 long	 PSNs	originate	 in	 the	 cervical	 enlargement	 (C3-C5)	 and	 travel	 in	 the	 ventral	 and	 lateral	funiculi	to	reach	the	neurons	in	the	ventral	horn	of	the	lumbosacral	enlargement.	They	are	 responsible	 for	 forelimb	 and	 hindlimb	 coupling.	 Some	 short	 PSNs	 have	 been	described	arising	from	the	C3-C4	cervical	segment	and	reaching	C6-T1	segments.	They	are	 involved	 in	 visually	 guided	 forelimbs	 movements	 (Bareyre	 et	 al.,	 2004).	 Recent	studies	 demonstrated	 the	 potential	 of	 the	 propriospinal	 pathway	 to	 support	 motor	recovery	in	incomplete	spinal	cord	injuries.	
Physiopathology	of	SCI	The	 spinal	 cord	 is	 well	 protected	 in	 the	 middle	 of	 the	 spine.	 Nevertheless,	 when	 the	integrity	of	the	spine	is	compromised,	the	spinal	cord	can	undergo	different	insults	such	as	 contusion,	 laceration,	 transection,	 etc.	 In	 the	 acute	 phase,	 the	 primary	 injury	mechanism	 causes	 direct	 death	 of	 the	 different	 cells	 at	 the	 impact	 site	 and	 plasma	membranes	 compromise	 leading	 to	 ionic	 homeostasis	 modifications	 and	neurotransmitter	 accumulation	 (Thuret,	 Moon,	 &	 Gage,	 2006).	 The	 initial	 impact	 also	leads	 to	 vascular	 damage	 with	 local	 rupture	 of	 the	 blood-spinal	 cord	 barrier	 rapidly	accompanied	by	the	infiltration	of	blood-derived	cells	and	blood	components	infiltrating	the	 lesion	 to	 resolve	 hemorrhage	 phenomenon.	 In	 addition,	 platelet	 influx	 signals	 to	
		 				local	 cells	 to	 produce	 extracellular	 matrix	 component	 such	 as	 collagen,	 laminin	 and	fibrin	allowing	neutrophils,	macrophages	and	other	leukocytes	infiltrating	the	lesion	to	monitor	 for	 pathogens,	 remove	 debris	 and	 provide	 wound	 repair	 signals	 (Burda	 &	Sofroniew,	2014).	Local	rupture	of	the	blood-spinal	cord	barrier	causes	tissue	swelling	through	accumulation	of	fluid	(edema)	at	the	damaged	site	exacerbating	tissue	damage.	After	the	initial	mechanical	damage,	a	cascade	of	vascular,	cellular	and	chemical	events	arises	 and	 causes	 further	 tissue	 loss	 and	 dysfunction	 (secondary	 injuries).	 Vascular	damages	reduce	blood	flow	resulting	in	tissue	ischemia	leading	in	nutrient	deprivation,	metabolic	stress,	liberation	of	reactive	oxygen	species	(ROS)	causing	neuronal	and	glial	apoptosis	 in	 the	 vicinity	 of	 the	 lesion	 (Hagg	&	Oudega,	 2006).	 Permeabilisation	of	 the	blood-spinal	 cord	barrier	promotes	 the	 infiltration	of	 systemic	 inflammatory	 cells	 and	proinflammatory	 molecules	 (Il-6,	 TNF-alpha...),	 which	 increase	 the	 extent	 of	 the	inflammatory	response	necessary	for	the	clearance	of	debris	but,	at	the	same	time,	can	exert	a	toxic	effect	on	neurons	and	glial	cells	exacerbating	the	injury	(Oyinbo,	2011).	In	a	second	phase	of	the	inflammatory	response,	a	shift	toward	anti-inflammatory	cells	(M2	macrophages)	 and	 cytokines	 (IL-10)	 occurs	 and	 promotes	 tissue	 repair	 (David	 &	Kroner,	 2011).	 Immune	 suppression	 experiment	 has	 failed	 to	 exert	 any	 benefit	suggesting	 that	 both	 inflammatory	 phase	 responses	 are	 likely	 crucial	 for	 homeostasis	within	immunity	(Schwab,	neurobiology,	2014,	n.d.).	Another	aspect	of	the	acute	phase	is	 the	 glutamate	 concentration	 increase	 that	 causes	 glutamate-induced	 excitotoxicity	affecting	especially	neurons	and	oligodendrocytes	-	that	express	a	lot	a	GLUT	receptors	–	through	apoptotic	process	leading	to	demyelination	of	healthy	axons	(Oyinbo,	2011).	Severed	 axons	 then	 undergo	 the	 so-called	 Wallerian	 degeneration	 process,	 in	 which	axons	die-back	towards	the	cell	body.	They	generally	survive	but	fail	to	regrowth	due	to	the	lack	of	trophic	support	and	growth	program	(Plunet,	Kwon,	&	Tetzlaff,	2002).		After	the	 acute	 inflammation	 phase,	 the	 lesion	 enters	 a	 phase	 of	 proliferation	 and	 cell	replacement.	 Different	 types	 of	 cells	 including	 fibroblast	 lineage	 cells,	 inflammatory	cells,	 endothelial	 cells,	 neural	 and	 glial	 lineal	 progenitor	 cells	 and	 scar-forming	astrocytes	 migrate	 toward	 the	 lesion.	 Astrocytes	 encounter	 a	 functional	 and	morphological	transformation	and	migrate	at	the	periphery	of	the	lesion	in	the	so-called	astrogliosis	process.	During	this	process	the	lesion	segregates	into	three	compartments:	i)	 a	 core	 of	 non-neural	 tissue	 in	 the	 center	 of	 the	 lesion	 (=	 fibrotic	 scar)	 ii)	 a	 dense	astrocyte	scar	(=	the	glial	scar)	surrounding	the	 lesion	core	 iii)	a	 transition	peri-lesion	perimeter.	The	fibrotic	lesion	core	does	not	enable	conduction	of	information	across	the	SCI	site,	because	of	 its	cellular	composition	(fibroblast	 lineage	cells,	 inflammatory	cells	and	 endothelial	 cells).	 In	 addition,	 it	 expresses	 different	molecules	 such	 as	 collagen-1	and	 chondroitin	 sulfate	proteoglycans	 (CSPGs)	 that	 are	 thought	 to	 inhibit	 regrowth	of	damaged	 axons.	 In	 the	 other	 hand,	 the	 fibrotic	 scar	 appears	 to	 contribute	 to	 restore	tissue	homeostasis	by	preventing	 the	extension	of	 the	 lesion	 to	 surrounding	 tissue.	 In	addition	 to	 regrowth	 inhibition	 the	 fibrotic	 scar	 has	 been	 considered	 as	 a	 physical	barrier	 to	 growing	 axons	 (Soderblom	 et	 al.,	 2013).	 In	 some	 areas	 of	 the	 fibrotic	 scar,	
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fluid	 cystic	 formations	 of	 variable	 size	 can	 growth	 (Burda	 &	 Sofroniew,	 2014).	 The	second	 part	 of	 the	 lesion,	 the	 glial	 scar,	 is	 composed	 of	 scar-forming	 astrocyte	 tightly	assembled	around	the	fibrotic	lesion	core.	Acutely,	they	exert	a	neuroprotective	function	by	restricting	the	spread	of	inflammatory	cells	into	the	surrounding	healthy	tissue.	The	peri-lesion	 perimeter	 is	 composed	 of	 a	 viable	 neural	 tissue	 containing	 reactive	 gliosis	that	 gradually	 decreases	 when	 reaching	 healthy	 neural	 tissue	 (Anderson	 et	 al.,	 2016;	Burda	&	Sofroniew,	2014).	Different	phenotypes	of	 astrocytes	 can	 arise	depending	on	the	 inflammatory	 conditions.	 For	 example,	 in	 the	 context	 of	 neuroinflammatory	 and	neurodegenerative	disease	reactive	astrocytes	express	a	cytotoxic	A1	phenotype,	which	is	detrimental	to	support	and	maintain	new	synapses	and	to	phagocyte	myelin	debris.	In	addition,	 this	 A1	 phenotype	 appears	 to	 be	 toxic	 toward	 injured	 neurons	 and	 existing	synapses	(Liddelow	et	al.,	2017).	In	case	of	traumatic	axotomy	astrocytes	express	a	A2	transformation,	 which	 appears	 to	 support	 neuron	 survival	 and	 axon	 regeneration	(Anderson	et	al.,	2016).	These	works	suggest	 that	 the	cellular	mechanisms	 involved	 in	response	 to	 SCI	 are	 complex	 and	 that	 the	 glial	 scar	 is	 primordial	 for	 balancing	 the	necessity	to	clear	the	debris	of	dead	cells	and	sparing	the	maximal	of	healthy	tissue.	
Spontaneous	plasticity	and	recovery	The	 spontaneous	 repair	 capacity	 of	 the	mammalian	 adult	 spinal	 cord	 is	 very	 limited.	Indeed,	almost	no	neurogenesis	can	occur	and	long-distance	regeneration	of	CNS	fibers	does	 not	 take	 place.	 However,	 compensatory	 reorganization	 occurs	 in	 multiple	descending	 motor	 systems,	 which	 sprout	 and	 innervate	 denervated	 spinal	 target	promoting	 some	 extent	 of	 recovery	 that	 relies	 on	 the	 density	 of	 spared	 fibers	 (Filli	 &	Schwab,	 2015).	 In	 addition,	 new	 glial	 precursor	 cells	 can	 arise,	 axon	 sprouting	 takes	place	 (Beattie	et	al.,	1997),	and	compensatory	rewiring	can	rely	on	spinal	and	cortical	plasticity	 (Raineteau	&	Schwab,	2001;	Weidner,	Ner,	 Salimi,	&	Tuszynski,	2001)	 It	has	been	show	that	new	spinal	circuits	can	bypass	the	lesion	via	sprouting	of	the	CST	tract	and	promote	 functional	 recovery	after	 incomplete	SCI.	 Indeed,	Bareyre	and	colleagues	demonstrated	that	after	a	mid-thoracic	dorsal	spinal	cord	hemisection	in	rat,	CST	axons	sprout	 and	 connect	 with	 long	 PSNs,	 which	 in	 turn	 increase	 their	 arborization	 and	control	 over	 lumbar	motor	neurons.	These	newly	 formed	propriospinal	 relays	 restore	CST	 electrophysiological	 conduction	 below	 the	 injury,	 as	 well	 as	 functional	 recovery	(Bareyre	 et	 al.,	 2004).	 In	 addition,	 in	 non-human	 primate	 model	 of	 spinal	 cord	hemisection,	it	was	demonstrated	that	the	contra	lesional	corticospinal	tract	can	sprout	and	 reconnect	 lumbar	 circuits	 below	 the	 injury	 (Rosenzweig	 et	 al.,	 2010).	 The	implication	of	propriospinal	relays	in	spontaneous	functional	recovery	was	confirmed	in	rodent	model	of	 incomplete	spinal	cord	 injury.	After	performing	two	staggered	double	hemisections	 performed	 at	 different	 time	 points,	 it	 was	 shown	 the	 animals	spontaneously	 recovered	 full	weight-bearing	 locomotion,	while	 stepping	was	 restored	(Courtine	 et	 al.,	 2008).	 These	 studies	 demonstrated	 the	 pivotal	 role	 of	 spared	 neural	tissue,	 such	 as	 the	 propriospinal	 system,	 in	 the	 reorganization	 of	 circuits	 to	 bypass	incomplete	injury	site	after	SCI.		
		 				Spinal	cord	repair	strategies	
Cell	therapies	Cell	replacement	after	SCI	have	been	investigated	as	a	therapeutic	approach	for	decades.	As	previously	described,	the	non-neural	lesion	core	fails	to	support	axon	regrowth.	The	idea	is	thus	to	replace	dead	neurons	and/or	astrocytes	with	exogenous	cells	in	order	to	create	a	more	suitable	environment	for	axon	regrowth	(Thuret	et	al.,	2006).	At	the	same	time,	the	cellular	material	 is	used	to	replace	cystic	formations	and	form	bridges	across	the	lesion	site.	Other	mechanisms	are	hypothesized	to	mediate	functional	improvement	such	 as	 neuroprotection,	 neuronal	 relays	 formation,	 axons	 sprouting,	 myelin	regeneration,	 immunomodulation,	 glial	 scar	 modulation	 (Assinck,	 Duncan,	 Hilton,	Plemel,	&	Tetzlaff,	2017).	When	transplanted	cells	are	able	to	survive	and	form	synapses	with	host	neurons,	they	can	relay	descending	information	to	infra-lesional	circuits.	Prof	Tuszynski’s	 group	 demonstrated	 that	 embryonic	 neural	 stem	 and	 progenitor	 cells	(NSPCs)	grafted	 into	 transected	spinal	cord	of	rat	could	differentiate	 into	neurons	and	glial	cells,	fill	lesion’s	cavity,	extent	long-distance	axons	into	the	host	tissue	that	support	conduction	 of	 action	 potential	 across	 the	 lesion	 and	 support	 some	 functional	 benefits	(Lu	 et	 al.,	 2012).	 The	 same	 strategy	 demonstrated	 that	 human	 spinal	 cord	 neural	progenitor	 cells	 (NPCs)	 could	 improve	 forelimb	 motor	 function	 after	 cervical	 (C7)	hemisection	 in	 Rhesus	 monkey	 (Rosenzweig	 et	 al.,	 2018).	 Furthermore	 they	demonstrated	that	spinal	cord	NPCs	could	self-organize	in	partially	normal	spinal	cord	cytoarchitecture	 and	 receive	 appropriate	 innervation	 from	 regenerating	 host	 axons	projections	when	 transplanted	 in	 SCI	 in	 rat	 (Dulin	 et	 al.,	 2018).	 Another	 recent	 study	reported	 robust	 corticospinal	 axon	 regeneration	 associated	with	 recovery	 in	 forelimb	function	 after	 grafting	 NPCs	 into	 SCI’s	 site	 of	 rats	 (Kadoya	 et	 al.,	 2016).	 Relay	 grafts	appear	 to	 be	 an	 interesting	 strategy	 in	 restoring	 connectivity	 in	 the	 vicinity	 of	 SCI.	However,	 NSCPs	 are	 multipotent	 cells	 in	 the	 neural	 lineage	 that	 can	 self	 renew	 and	proliferate	 rapidly	 raising	 some	 safety	 concern	 related	 with	 tumoral	 transformation.	Various	other	candidate	cell	 types	have	now	been	explored	 in	different	models	of	SCI,	including	 Schwann	 Cells	 (SCs),	 Oligodendrocyte	 Progenitor	 Cells	 (OPCs),	 Olfactory	Ensheating	 Cells	 (OECs),	 mesenchymal	 stem	 cells	 (MSCs)	 for	 their	 ability	 to	 provide	neuroprotection,	 deliver	 trophic	 factors	 and	 promote	 axon	 regeneration	 to	 endogen	tissue	 (Assinck	 et	 al.,	 2017).	 For	 example	 Schwann	 cells	 have	 been	 demonstrated	 to	increase	 the	 spared	 fibers	 and	 tissue	 integrity,	 reduce	 cystic	 formation	 and	 enhance	functional	 recovery	 in	 contusion	model	 of	 SCI	 in	 rat	 (Barbour,	 Plant,	 Harvey,	&	 Plant,	2013).	They	are	known	to	produce	BDNF,	a	neuroprotective	agent.	 In	addition	to	their	neuroprotective	effect	SCs,	MSCs	and	OECs	have	also	been	demonstrated	to	bridge	SCI.	It	is	 likely	that	 the	trophic	 factors	secreted	by	these	non-neuronal	cells	contribute	to	the	regenerative	 effect	 (Lu	 et	 al.,	 2012).	Recently	 a	new	potential	 source	of	NSC	has	been	described	 in	 the	 Filum	 terminal	 (FT),	 which	 is	 a	 vestigial	 developmental	 structure	
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binding	the	medullary	cone	with	the	coccyx.	This	structure	has	been	shown	to	contain	neuronal	progenitor	cells	 that	can	proliferate,	and	slowly	differentiate	 in	vitro,	making	them	 less	 prone	 to	 induce	 malignancy	 (Chrenek,	 Magnotti,	 Herrera,	 Jha,	 &	 Cardozo,	2016;	 Jha,	 Liu,	 Chrenek,	 Madsen,	 &	 Cardozo,	 2013).	 We	 tested	 this	 approach	 and	reported	that	FT	cells	can	survive	in	vitro	and	form	neurospheres	composed	of	neurons,	oligodendrocytes	 and	 astrocytes.	However,	when	 transplanted	 into	 SCI	 sites	 in	 inbred	rats	 (autologous-like	 approach),	 their	 survival	 rate	 and	 ability	 to	 promote	 axon	regrowth	 through	 the	 SCI	was	 very	 limited	 despite	 co-injection	 of	 survival	 factor	 and	lesion	remodeling	factors.		In	 summary,	 numerous	 strategies	 based	 on	 cell	 replacement	 have	 been	 focusing	attention	 on	 exogenous	 tissue	 to	 obtain	 functional	 benefits	 by	 rewiring	 with	 the	neighboring	 healthy	 tissue	 and	 showed	 great	 potential	 but	 remain	 empirical	approaches.	 Indeed,	 the	 complexity	 of	 interactions	 between	 transplanted	 cells	 and	 a	host	 spinal	 environment	 renders	 both	 circuits	 control	 and	mechanistic	 understanding	difficult.	In	addition,	many	of	these	approaches	have	been	involving	stem	or	progenitor	cells,	 addressing	 concerns	 such	 as	 iatrogenic	 development	 of	 malignant	 mass,	immunological	rejection	and	rising	ethical	debate.	Finally,	it	seems	clear	that	combined	repair	 strategies	 are	 more	 prone	 to	 provide	 functional	 benefits,	 compared	 to	 cell	grafting	alone.	
 
Myelin-associated	inhibitors	As	previously	exposed,	axonal	regeneration	within	the	adult	CNS	is	very	limited.	Various	environmental	factors	have	been	described	as	axonal	growth	limiting	factors	associated	with	 myelin	 debris,	 the	 glial	 scar	 and	 axonal	 component	 after	 SCI	 (He	 &	 Jin,	 2016).	Chondroitin	 sulfate	 proteoglycans	 (CSPGs)	 are	 molecules	 that	 as	 been	 described	 to	inhibit	axon	growth	in	both	in-vitro	experiment	(SNOW,	BROWN,	of,	1996,	n.d.)	and	in	in-vivo	 experiment.	 Indeed,	 CSGPs	have	been	 suggested	 to	 be	upregulated	by	 reactive	astrocytes	after	SCI	supporting	the	idea	that	the	glial	scar	constitutes	the	major	obstacle	to	 regeneration	 in	 the	 CNS	 after	 SCI	 (Davies,	 Goucher,	 Doller,	 &	 Silver,	 1999).	 CSGPs	inactivation	 strategies	 have	 been	 performed	 with	 chondroitinase	 ABC	 (enzymatic	digestion),	which	promoted	regeneration	of	some	axonal	tracts	(Grimpe	&	Silver,	2004;	Mckeon,	 Höke,	 neurology,	 1995,	 1995).	More	 recent	work	 has	 shown	 that	 the	 proper	sensory	 axon	 regeneration	 can	 occurs	 after	 SCI	 without	 inhibiting	 CSCPs.	 level	 of	chondroitin	 sulfate	 proteoglycan	 (CSPGs)	 was	 not	 reduced	 by	 ablating	 scar-forming	astrocytes	showing	that	a	large	amount	of	CSPGs	is	produced	by	non-astrocyte	cells	and	that	 CSPGs	 inhibition	 can	 be	 overridden	 when	 correct	 growing	 cues	 are	 provided	(Anderson	 et	 al.,	 2016).	 Contrary	 to	 the	 CNS,	 the	 peripheral	 nervous	 system	 (PNS)	supports	axon	regeneration.	This	difference	led	to	the	discovery	of	a	myelin-associated	molecule,	NOGO,	which	is	expressed	in	oligodendrocytes	but	not	in	Schwann	(GrandPré,	Nakamura,	 Vartanian,	 Nature,	 2000,	 n.d.).	 In	 addition	 two	 other	molecules	 have	 been	identified	 as	 inhibitor	 in	 the	 CNS:	 Myelin-associated	 glycoprotein	 (MAG)	 and	oligodendrocyte-myelin-glycoprotein	(OMgp).	Different	groups	studied	the	potential	of	
		 				NOGO,	 OMps	 and	 MAG	 inhibition,	 but	 results	 were	 inconsistent	 in	 between	 studies	(Geoffroy	 &	 Zheng,	 2014).	 It	 was	 for	 instance	 demonstrated	 that	 antibodies	 against	NOGO	(anti-NOGO)	allowed	some	degree	of	axonal	regeneration	after	SCI	(Thallmair	et	al.,	 1998).	 Moreover,	 by	 deleting	 the	 three	 inhibitors	 (NOGO,	 MAG	 and	 OMgp)	 some	limited	 CST	 axon	 regeneration	 was	 also	 demonstrated	 (Cafferty,	 Duffy,	 Huebner,	 &	Strittmatter,	2010).	However,	another	group	reported	that	the	suppression	of	the	three	inhibitors	 failed	 in	 enhancing	 CST	 regeneration	 (Lee	 et	 al.,	 2010).	 	 This	 disparity	between	 studies	 about	 CSPGs	 as	 well	 as	 myelin-associated	 inhibitors	 highlights	 our	partial	understanding	of	the	mechanisms	involved.	Nevertheless,	modulation	of	growth	inhibitors	remains	a	good	candidate	to	promote	axonal	regeneration	in	the	CNS	but	will	require	 to	 be	 combining	 with	 others	 strategies	 (boosting	 the	 axonal	 intrinsic	 growth	capacity	for	instance)	to	elicit	robust	functional	recovery.		
Neuronal	intrinsic	growth	capacity	The	 growth	 potential	 of	 axons	 in	 the	 adult	 CNS	 is	 very	 limited	 after	 developmental	completion	 of	 axogenesis.	 Indeed,	 neuronal	 growth	 programs	 are	 upregulated	 during	development	until	the	axons,	attracted	and	repelled	by	guidance	molecules,	reach	their	final	 target.	Different	 intracellular	signaling	pathways	control	neuronal	growth	control	in	 a	 tract-dependent	manner.	 	 In	 2008,	 Zhigang	He’s	 lab	 analyzed	 potential	 candidate	genes	 for	 axon	 growth	 control,	 using	 a	 virus-knockdown	 approach.	 They	 found	 that	 a	deletion	of	PTEN	–	known	as	a	negative	regulator	of	the	mTOR	pathway	-	enhances	axon	regeneration	after	optic	nerve	injury	(Park	et	al.,	2008).	In	addition,	they	demonstrated	that	a	deletion	of	SOCS3,	a	negative	inhibitor	of	the	growth-controlling	STAT3	cascade,	further	 supports	 axon	 regeneration	 after	 optic	 nerve	 lesion	 (Smith	 et	 al.,	 2009).	 In	 a	combinatory	 approach,	 they	 demonstrated	 that	 a	 co-activation	 of	 mTOR	 and	 STAT3,	performed	with	a	co-suppression	of	PTEN	and	SOCS3,	promotes	robust	axonal	regrowth	after	 optic	 nerve	 crush	 (Sun	 et	 al.,	 2011).	 Exploring	 other	 axon	 tracts,	 Professor	 He’s	group	established	that	a	deletion	of	PTEN	also	promotes	CST	regeneration	past	SCI	(K.	Liu	et	al.,	2010).	However,	a	main	concern	regarding	this	approach	relies	on	PTEN	being	a	tumor	suppressor.	 Its	 inhibition	might	 lead	to	tumor	formation,	rendering	its	clinical	applications	 less	 realistic.	 Interestingly,	 it	 has	been	 shown	 that	 the	 activation	of	 three	specific	genes	can	induce	a	robust	axonal	growth	in	a	mTOR-dependent	manner	without	deleting	PTEN.	These	three	genes	code	for	the	growth	factors	insulin-like	growth	factor	1	 (IGF-1),	 ciliary	 neurotrophic	 factor	 (CNTF)	 and	 osteopontin	 (OPN).	Osteopontin	 has	also	been	shown	to	sensitize	the	CNS	to	growth	factors	(He	&	Jin,	2016).	This	approach	enabled	robust	regrowth	of	retinal	ganglion	cells	following	axotomy	(Duan	et	al.,	2015)	as	well	as	recovery	of	visual	function	(Bei	et	al.,	2016).	In	the	future,	this	manipulation	could	replace	genetic-base	deletion	of	PTEN	with	a	 temporal	 ligand-receptor	signaling	activation	 of	mTOR	 and	 STAT3	 signaling	 pathways,	making	 clinical	 applications	more	realistic.	 In	 2017,	 by	 overexpressing	 IGF1	 and	 OPN	 Prof.	 He’s	 group	 demonstrated	
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robust	CST	regrowth,	together	with	recovery	of	CST-dependent	behavioral	task	after	SCI	(Y.	Liu	et	al.,	2017).	
Glial	scar	(supportive	substrate)		A	major	aspect	of	CNS	regeneration	relies	on	modulations	of	the	glial	scar.	For	decades,	it	was	accepted	that	axon	regeneration	failure	in	the	adult	mammalian	CNS	was	due	to	the	reactive	astroglial	scar.	 Indeed,	 it	was	reported	that	axon	regeneration	 is	 inhibited	exactly	 at	 the	 border	 of	 the	 glial	 scar,	 where	 the	 level	 of	 chondroitin	 sulphate	proteoglycans	(CSPGs)	in	higher.	CSGPs	inhibit	axons	growth	both	in-vitro	and	in-vivo.	It	was	 argued	 that	 the	 glial	 scar	 acts	 as	 a	 dense	 physical	 and	 chemical	 barrier	 to	 axon	regeneration	(Davies	et	al.,	1999).	However,	our	better	understandings	of	the	glial	scar	process	 slowly	 challenge	 the	 detrimental	 role	 in	 regeneration	 of	 this	 structure.	 As	previously	explained,	 the	scaring	process	after	spinal	cord	 injury	organize	 in	a	 fibrotic	lesion	core	corresponding	to	 the	 fibrotic	scar	and	a	dense	astroglial	 layer	surrounding	the	 lesion	 core	 corresponding	 to	 the	 glial	 scar.	 Both	 the	 astroglial	 and	 fibrotic	components	 appears	 to	 contribute	 on	 restoring	 tissue	 homeostasis	 by	 preventing	 the	extension	of	the	lesion	in	acute	phase	(Burda	&	Sofroniew,	2014).	However,	the	fibrotic	scar	 have	 been	 shown	 to	 support	 detrimental	 effect	 on	 axons	 regrowth	 and	 to	 be	 a	physical	barrier	to	growing	axons	in	chronic	stage	(Soderblom	et	al.,	2013).	Recently,	it	has	 been	 demonstrated,	 conversely	 to	 the	 persisting	 dogma,	 that	 the	 astroglial	component	 of	 the	 SCI	 scar	 supports	 axon	 regeneration,	 depending	 on	 the	 astrocytes	phenotype.	 Indeed,	 astrocytes	 expressing	 A2	 phenotype	 transformation	 appears	 to	support	neuron	survival	and	axon	regeneration	(Anderson	et	al.,	2016;	Liddelow	et	al.,	2017).	 Anderson	 and	 colleagues	 demonstrated	 that	 upregulating	 laminin	 levels	 (a	permissive	matrix	molecule	produced	by	astrocytes	and	pericytes)	in	combination	with	neurotrophic	factor	delivery	(NT3	and	BDNF)	allowed	robust	axon	regrowth	trough	and	beyond	 the	 glial	 scar.	 In	 addition,	 they	 demonstrated	 that	 preventing	 astrocyte	 scar	formation	 reversed	 the	 beneficial	 effect	 of	 the	 treatment	 on	 ascending	 sensory	 axons	regrowth.	These	results	provide	strong	evidence	that	astroglial	component	of	the	lesion	supports	 axon	 regrowth,	 as	 long	 as	 the	 growth	 signaling	 is	 provided	 (Anderson	 et	 al.,	2016)	and	that	scar	modulation	may	create	a	more	permissive	environment	to	promote	axon	 regeneration.	 For	 instance,	 laminin	 concentration	 in	 the	 lesion’s	 environment	 is	crucial	for	axon	regeneration.	It	has	been	shown	that	a	combination	of	epithelial	growth	factor	 (EGF)	 and	 fibroblast	 growth	 factor	 (FGF)	 modulates	 the	 SCI	 lesion	 core	 and	increases	 the	 extracellular	 matrix	 density,	 which	 is	 largely	 composed	 of	 laminin	 and	collagen-1	 (Anderson	 et	 al.,	 2018;	 Kashpur,	 LaPointe,	 Ambady,	 Ryder,	 &	 Dominko,	2013).	
Axonal	guidance	(chemoattraction)	Lesion	 core	 remodeling	 by	 itself	 does	 not	 induce	 axon	 regrowth.	 Indeed,	 chemo-attractant	 factors	 are	 required	 to	 guide	 axons	 into	 and	 beyond	 the	 lesion.	 Several	molecules	 have	 been	 documented	 as	 growth	 and	 plasticity	 stimulants,	 such	 as	 brain-derived	 neurotrophic	 factor	 (BDNF),	 neurotrophin-3	 (NT3),	 glial	 cell-derived	
		 				neurotrophic	 factor	 (GDNF).	 NT3	 and	 BDNF	 have	 been	 shown	 to	 exert	 guidance	 on	sensory	fibers.	 In	addition,	some	evidence	grants	BDNF	with	attractant	abilities	on	the	reticulospinal	 tract	 (RtST)	 (Alto	 et	 al.,	 2009;	 K.	 Liu,	 Tedeschi,	 Park,	 &	 He,	 2011;	Madhavan	&	Collier,	2010;	Tuszynski	&	Lu,	2008).	
Neuroprosthetics		As	 previously	 described,	 axon	 regrowth	 interventions	 or	 cell-based	 therapies	 are	currently	 insufficient	 to	 yield	 recovery	 after	 complete	 SCI.	 Different	 paradigms	 have	been	developed	for	a	more	 immediate	patient	care	 in	case	of	SCI.	 In	most	of	 the	cases,	SCI	 are	 incomplete,	 leaving	 some	 extent	 of	 spared	 tissue.	 In	 addition,	 the	 spinal	networks	coordinating	leg	movements,	known	as	locomotor	central	pattern	generators	(CPG)	 located	 within	 the	 lumbar	 spinal	 cord	 (Gerasimenko,	 Roy,	 &	 Edgerton,	 2008),	remain	 intact	 in	 a	 “dormant”	 state.	 These	 circuits	 are	 modulating	 by	 brainstem	descending	pathways	mediated	by	different	molecules	such	as	noradrenaline,	serotonin	(5-HT),	dopamine	and	glutamate	(Asboth	et	al.,	2018;	Hentall,	Mesigil,	Pinzon,	&	Noga,	2003;	 Zaporozhets,	 Cowley,	 &	 Schmidt,	 2011).	 It	 has	 been	 demonstrated	 that	 the	delivery	of	5-HT	and	dopaminergic	agonists	can	stimulate	these	circuits	and	potentiate	gait	pattern	(Musienko,	van	den	Brand,	Maerzendorfer,	Larmagnac,	&	Courtine,	2009),	making	monoaminergic	agents	good	candidates	in	potentiating	(increasing	excitability)	infralesional	 spared	 circuits	 after	 SCI.	Moreover,	 the	 recruitment	 of	 quiescent	 circuits	below	SCI	can	also	be	achieved	by	targeted	epidural	electrical	stimulation	(EES).	It	has	been	shown	that	EES	associated	with	serotoninergic	agonists	stimulation	and	treadmill	motor	 training	 can	 restore	 a	 functional	 state	 of	 lumbosacral	 circuits	 enabling	 full	weight-baring	 treadmill	 locomotor	 capacity	 after	 complete	 SCI	 (Courtine	 et	 al.,	 2009).	Nevertheless,	 this	 electropharmacollogical	 circuit’s	 recruitment	 associated	 with	locomotor	 treadmill	 training	allowed	generating	 involuntary	movements	meaning	 that	supraspinal	 inputs	were	not	 involved.	Prof.	Grégoire	Courtine	and	his	 lab	went	further	by	building	a	postural	robotic	interface	that	provide	rodents	with	body	weight	support,	enabling	volitional	bipedal	training	on	a	treadmill	or	overground.	Rats	were	submitted	to	 staggered	 double	 hemisections	 (T7	 and	 T10)	 and	 were	 treated	 subsequently	 with	systemic	 serotoninergic	 (5-HT)	 agonists,	 combined	 with	 electric	 epidural	 stimulation	below	 the	 injury.	 Rats	 underwent	 an	 intensive	 robotic-assisted	 training	 overground	associated	with	motivational	cues	to	promote	an	active	participation	of	the	animals.	This	training	 resulted	 in	 the	 restoration	 of	 supraspinal	 (voluntary)	 leg	movements,	 arising	from	cortical	projections	remodeling	and	the	formation	of	new	propriospinal	relays,	 in	an	 activity-dependent	 manner	 (van	 den	 Brand	 et	 al.,	 2012).	 The	 same	 group	 also	demonstrated	 that	 electrochemical	 neuromodulation	 of	 lumbar	 circuits	 after	 severe	spinal	cord	contusion	enabled	a	supraspinal	control	over	paralyzed	 legs.	They	showed	that	 glutamatergic	 reticulospinal	 neurons	 in	 the	 VGI	 relay	 cortical	 commands	 and	support	 functional	 recovery	after	 incomplete	SCI.	This	 so-called	cortico-reticulo-spinal	circuit	 allowed	 rats	 with	 a	 severe	 spinal	 contusion	 to	 walk,	 swim	 and	 climb	 stairs	
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(Asboth	 et	 al.,	 2018)	 after	 hard	 training.	 Furthermore,	 walking	 involves	 alternating	activation	of	 flexor	and	extensor	muscles	 synergies	 restricted	 in	different	hot	 spots	 in	the	spinal	cord.	It	was	demonstrated	that	a	precise	spatiotemporal	neuromodulation	of	these	hot	spots	improved	important	gait	and	balance	features	after	complete	SCI	in	rat	(Wenger	 et	 al.,	 2016),	 non-human	 primates	 (Capogrosso	 et	 al.,	 2016)	 by	 recruiting	proprioceptive	 circuits	 within	 the	 posterior	 roots	 of	 the	 spinal	 cord.	 It	 was	demonstrated	 that	 spatiotemporal	 EES	 during	 gravity-assisted	 overground	 intensive	locomotor	 training	 enabled	 restoring	 voluntary	 control	 of	 walking	 in	 patients	 with	incomplete	 SCI.	 Patients	 improved	 their	 walking	 capacities	 after	 this	 neuroprosthetic	rehabilitation	program	and	the	 functional	 improvement	was	persistent	over	time	even	without	 EES	 probably	 through	 propriospinal	 circuits	 activation	 (Wagner	 et	 al.,	 2018).	These	 studies	 highlighted	 the	 pivotal	 role	 of	 both	 propriospinal	 and	 reticulospinal	systems	 in	 the	 recovery	 after	 incomplete	 spinal	 cord	 injuries.	 After	 such	 assaults,	 the	CNS	 reorganize	 through	 spared	 descending	 motor	 pathways.	 Indeed,	 propriospinal	circuits	 were	 shown	 to	 be	 critical	 in	 recovery	 after	 staggered	 double	 hemisections	experiment	(van	den	Brand	et	al.,	2012),		probably	du	to	their	centromedullary	location.	In	the	other	hand,	in	contusions	experiments	where	ventrolateral	reticulospinal	circuits	are	 spared	 (Asboth	 et	 al.,	 2018),	 the	 reticulospinal	 neurons	 supported	 the	 recovery.	However,	in	case	of	complete	spinal	cord	injuries	(SCI),	which	isolate	the	circuits	under	the	lesion	from	any	supraspinal	control,	the	outcome	of	neuroprosthetic	rehabilitation	is	still	 not	 sufficient.	 Ideally,	 it	 will	 require	 the	 restoration	 of	 both	 propriospinal	 and	reticulospinal	 across	 the	 injury,	 and/or	 the	 replacement	of	 the	 loss	neural	 tissue	with	exogenous	cells	that	can	either	support	regrowth,	or	relay	information.		The	project	Neuroprosthetic	rehabilitation	demonstrated	that	significant	functional	benefit	could	be	achieved	with	lumbosacral	neuromodulation	after	of	spinal	cord	injury.	It	promoted	the	recovery	 of	 voluntary	 leg	 movements	 through	 the	 reorganization	 of	 residual	reticulopinal	and	propriospinal	projection	pathways	(Asboth	et	al.,	2018;	van	den	Brand	et	al.,	2012).	However,	 in	case	of	complete	spinal	cord	 injuries	(SCI),	which	 isolate	 the	circuits	under	the	lesion	from	any	supraspinal	control,	the	outcome	of	neuroprosthetic	rehabilitation	 is	 still	 not	 sufficient.	 Indeed,	 it	 will	 require	 the	 restoration	 of	 robust	regrowth	 and	 sprouting	 of	 several	 types	 of	 axons	 across	 the	 injury.	 However,	 adult	mammalian	injured	axons	fail	to	regrow	into	complete	SCI	because	of	i)	the	low	intrinsic	growth	capacity	of	adult	CNS	neurons,	ii)	a	lack	of	supportive	intralesional	environment	and	 iii)	 a	 lack	 of	 guidance	 cues.	 These	 three	 essential	 components	 are	 required	 for	proper	axon	extension	during	development	but	are	attenuated	in	adults.	Anderson	and	colleagues	 demonstrated	 that	 all	 three	 components	 are	 individually	 necessary	 and	sufficient	 in	 combination	 to	promote	 robust	 regrowth	across	 complete	 SCI	 in	 rodents.	They	reactivated	the	intrinsic	growth	capacity	of	descending	propriospinal	neuron	with	viral	activation	of	IGF1,	CNTF	and	OPN	prior	complete	SCI	(Bei	et	al.,	2016;	Duan	et	al.,	2015);	 induced	 growth-supportive	 environment	 with	 	 FGF2	 and	 EGF	 and	 attracted	
		 				propriospinal	 axons	 with	 GDNF	within	 and	 below	 the	 injury.	 They	 reported	 a	 robust	propriospinal	axon	regeneration,	that	regrew	a	full	spinal	segment,	formed	terminal-like	contact	 within	 healthy	 tissue	 below	 the	 injury	 and	 conveys	 electrophysiological	conduction	 capacity	 through	 anatomically	 complete	 SCI	 (Anderson	 et	 al.,	 2018).	However,	 this	 robust	 propriospinal	 bridging	 failed	 to	 promote	 by	 itself	 functional	recovery,	which	is	consistent	with	accumulative	evidences	that	new	projections	formed	after	 complete	 SCI	 require	 active	 rehabilitation	 to	 support	 their	 integration	 into	functional	neural	networks.	 In	addition,	 it	might	be	partly	explained	by	an	 insufficient	descending	motor	control	partly	supported	by	other	systems	such	as	the	reticulospinal	tract	 (RtST)	 and	 the	 corticospinal	 tract	 (CST).	 We	 propose	 here	 to	 translate	 the	established	procedure	 to	 the	 regeneration	of	 both	 the	 corticospinal	 and	 reticulospinal	tract	after	a	complete	spinal	cord	injury.	We	first	activated	the	neuronal	intrinsic	growth	capacity	 of	 both	 tracts	 using	 viral	 activation	 of	 IGF1,	 CNTF	 and	 OPN,	 that	 co	 activate	mTOR,	 STAT	 and	 probably	 others	 pathways.	 The	 lesion	 environment	 was	 then	remodeled	 with	 delivery	 of	 FGF2	 and	 EGF	 that	 demonstrated	 to	 increase	 the	extracellular	 matrix	 density	 mainly	 composed	 of	 laminin,	 which	 crucial	 for	 axons	regeneration	 (Anderson	 et	 al.,	 2018).	 Finally,	 we	 established	 chemical	 axon	 guidance	using	 chemo-attractant	 molecules.	 These	 interventions	 were	 delivered	 with	 a	spatiotemporal	profile	corresponding	to	the	axon	growth	sequence	during	development.	GDNF	 delivery	 was	 demonstrated	 to	 decrease	 reticulospinal	 axons	 retraction	 axons	after	SCI	(Dolbeare	&	Houle,	2003).	BDNF	was	reported	to	promote	survival	axotomized	axons	and	promote	their	elongation	in	synergy	with	IGF-1.	NT3	was	argued	to	promote	sprouting	of	CST	axons	(K.	Liu	et	al.,	2011)	and	allowed	attraction	of	sensitive	fibers	in	combination	with	BDNF	 (Anderson	et	 al.,	 2016).	We	hypothesize	 that	 IGF-1	 itself	may	exert	guidance	on	selected	axon	 tracts,	when	delivered	at	 the	severed	axon	extremity.	The	 present	work	 aims	 at	 investigating	 the	 ability	 of	 NT3,	 BDNF,	 GDNF	 and	 IGF-1	 to	properly	attract	severed	CST	and	RtST	axons.	To	enable	proper	delivery	of	these	factors	in	a	sustained	and	reliable	manner,	a	biocompatible	hydrogel	was	used	as	vehicle.	This	material	 –	 termed	 diblock	 copolypeptide	 hydrogel	 (DCH)	 –	 was	 developed	 by	 our	colleagues	from	the	Deming	Laboratory	[University	of	California,	Los	Angeles,	UCLA]	as	an	amphiphile	carrier	for	a	broad	variety	of	cargo	molecules	and/or	cells	(Anderson	et	al.,	2016;	2018;	Nowak	et	al.,	2002;	Zhang	et	al.,	2014).			
Research	question:	
Does	 neuronal	 overexpression	 of	 the	 factors	 IGF	 1	 -	 CNTF	 –	 OPN,	 associated	 to	 lesion	
remodelling	 and	 chemoattraction	 enable	 robust	 regeneration	 of	 corticospinal	 and	
reticulospinal	bridges	across	complete	spinal	cord	injuries?	
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Methods	Experiments	were	conducted	on	six	young	adult	female	Lewis	rats	ranging	from	2	to	4	months	old	and	between	180	g	to	220	g	body	weight	at	the	beginning	of	the	experiment.	They	were	 housed	 in	 a	 pathogen-free	 facility,	 three	 animals	 per	 cage,	 with	 unlimited	access	 to	 food	 and	 water.	 Four	 animals	 received	 the	 full	 treatment	 and	 two	 control	animals	 received	empty	vehicle	only.	The	experiment	was	 conducted	over	42	days,	 as	shown	in	the	following	timeline	(fig.	2).	All	procedures	were	conducted	according	to	the	Swiss	 Veterinary	 Law	 guidelines	 and	 approved	 by	 the	 Veterinary	Office	 of	 the	 canton	Geneva.	
	
Fig.	2.	Timeline	of	the	experiment.	Day	0	corresponds	to		the	time	point	for	the	spinal	cord	injury.	Two	weeks	before	(d	-14)	
the	ICO		viral	injection	is	performed.	On	day	2	post-lesion,	the	first	depot	was	performed	into	the	lesion	site	as	well	as	BDA	
tracing	of	the	motor	cortex	and	AAV5-RFP	tracig	of	the	reticular	formation.	On	day	9	the	second	depot	was	performed	into	
the	healthy	spinal	cord	located	below	the	level	of	injury.	On	day	28,	animals	were	sacrificed	and	the	CNS	was	recovered	for	
histological	analysis.		
Experimental	design	The	 activation	 of	 the	 three	 genes	 of	 interest	 (IGF-1,	 CNTF	 and	OPN)	 relied	 on	Adeno-Associated-Virus	 2/9	 (i.e.	 AAV2/9	 IGF-1,	 AAV2/9	 CNTF	 and	 AAV2/9-OPN).	 Fourteen	days	prior	to	spinal	cord	injury	(SCI)	(Day	-14	=	D-14),	the	three	viruses	were	combined	and	 injected	 into	both	 the	motor	 cortex	 and	 the	 ventral	 gigantocellular	nucleus	 (VGI).	Two	weeks	were	respected	for	gene	expression	of	the	signaling	factors	(IGF-1,	CNTF	and	OPN)	(fig.3).	
	
Fig.	3	.	Day	-14:	injection	of		(AAV9-IGF1+AAV9-CNTF+AAV9-OPN)	in	the	left	somatosensory	cortex	(6	injections	sites)	and	in	
the	ventral	gigantocellular	nucleus	(VGI)	(2	injections	sites)	
		 				
	
Fig	4.	Day	0:	Complete	crush	spinal	cord	injury	(SCI)	at	thoracic	level	10	(T10)		Fourteen	days	after	viral	activation	of	the	targeted	signaling	cascades,	a	complete	crush	SCI	(corresponding	to	day	0	=	DO)	was	performed	at	thoracic	level	10	of	the	spinal	cord	(T10)	(fig.4).	Two	days	after	SCI	(Day	2	=	D2)	a	first	growth	factor	depot	was	performed	into	 the	 lesion	 site	 for	 core	 remodeling.	 Diblock	 copolypeptide	 hydrogel	 (DCH)	 was	loaded	with	cargo	EGF	and	FGF	(lesion	core	modulators),	as	well	as	BDNF,	GDNF,	IGF-1	and	NT3	(guidance	cues).	During	the	same	surgical	procedure,	the	CST	was	labeled	with	BDA	and	the	RtST	was	traced	using	AAV5-TurboRFP	(fig.5).	
	
Fig.	5.	Day	2:	First	depot	into	the	lesion	site	(EGF-FGF-BDNF-GDNF-IGF1-NT3).	Labelling	of	the	CST	with	BDA	and	tracing	of	
the	RtST	with	RFP2.		One	week	later	(Day	9=	D9)	staggered	bilateral	depots	were	performed	i)	2	mm	below	the	lesion	on	the	right	hemi-cord	and	ii)	3	mm	below	the	lesion	on	the	left	side.	For	the	second	depot,	DCH	was	loaded	with	guidance	molecules	(BDNF,	GDNF,	IGF-1	and	NT3)	alone	 (fig.6).	 Four	weeks	after	SCI	 (Day	28	=	D28)	 the	animals	were	 scarificed	with	a	pentobarbital	 overdose	 and	 the	 CNS	was	 collected	 for	 anatomical	 analysis.	 In	 parallel	control	animals	only	underwent	complete	crush	SCI	and	labeling	of	both	tract,	without	any	 further	 therapeutic	 treatment.	 Control	 animals	 were	 involved	 to	 quantify	 any	spontaneous	axon	regeneration.		
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Fig.	6.	Day	9:	Second	deposits	below	the	lesion.	One	deposit	was	performed	2mm	below	the	lesion	site	on	the	right	side	and	
one	deposit	was	performed	3mm	below	the	lesion	site	on	the	left	side.		
Specific	signaling	and	gene	activation	Specific	 signaling	 and	 gene	 activation	 was	 performed	 using	 adeno-associated	 virus	(AAV)	 to	 infect	 neurons	with	 plasmids	 carrying	 the	 genes	 of	 interests.	 In	 the	 present	study	 AAV2/9	 vectors	 were	 used	 as	 vectors	 to	 co-express	 the	 growth	 factors	 IGF-1,	CNTF	and	OPN	(fig.7).	These	recombinant	vectors	are	composed	of	a	packaging	vector	AAV2	rep,	AAV9	cap	and	our	gene	of	interest	with	the	following	dilution:	AAV2/9	IGF-1:	5	 x	 1012	 genome	 copies	 per	 ml,	 AAV2/9-OPN:	 1	 x	 1013	 genome	 copies	 per	 ml	 and	AAV2/9	 CNTF:	 5	 x	 1012	 genome	 copies	 per	 ml.	 In	 addition,	 labeling	 of	 the	 RtST	 was	performed	using	a	red-fluorescent	protein	(RFP)	reporter,	which	was	administered	with	an	AAV2/5-RFP	vector	(2.612	x	1013	genome	copies	per	ml).		
	
Fig.	7.	Molecular	mecanisms.	The	three	adeno-associated	viruses	were	used	as	pictured	with	green	hexagones.	Expression	of	
the	three	corresponding	genes	(e.g.	 IGF-1,	CNTF	and	OPN)	 is	enhanced	in	both	targeted	regions.	Expression	of	these	genes	
aimed	at	reactivating	axon	growth	capacities	via		mTOR,	STAT3	and	probalby	others	signaling	pathways	.	
		 				
Hydrogel	and	growths	factors	Biomaterial	 depots	 were	 performed	 using	 diblock	 copolypeptide	 hydrogel	 K180-L20	(DCH),	known	as	a	well	characterized	CNS	biocompatible	vehicle	that	enables	prolonged	delivery	of	bioactive	molecules	to	the	CNS	and	self-degrades	in	three	weeks	(Anderson	et	al.,	2016;	2018;	Nowak	et	al.,	2002;	Zhang	et	al.,	2014).	Freeze-dried	K180-L20	polymer	(provided	by	our	collaborators	 from	the	Deming	Laboratory,	UCLA)	was	reconstituted	to	 a	 3%	 hydrogel	 in	 phosphate-buffered	 saline	 (PBS)	 and	 cargo	 growth	 factors	 were	added	when	applicable:	EGF,	FGF,	BDNF,	NT3,	GDNF,	IGF-1	(1μg/μl	each).	
Surgical	procedures	All	 surgical	 procedures	 were	 performed	 under	 general	 anesthesia.	 Before	 surgery,	animals	were	 sedated	with	 a	mixed	 atmosphere	 of	 5%	 isoflurane,	O2	 (1,5	 L/min)	 and	ambient	air	 (1,5	L/min)	 for	5	minutes.	 In	addition	and	 to	 complete	analgesia,	 animals	received	 0,05	 mg	 of	 medetomidine	 hydrochloride	 (Dorbene®).	 After	 anesthetic	induction,	 head	 and	 back	 were	 shaved	 and	 disinfected	 with	 a	 1:1	 combination	 of	Betadine	 and	 hydrogen	 peroxide	 (H2O2).	 Animals	 were	 kept	 stable	 under	 anesthesia	with	1,5%	to	2,5%	isoflurane	in	oxygen-enriched	air.			
Brain	surgery	For	 motor	 cortical	 and	 brainstem	 injections,	 rats	 were	 placed	 in	 a	 stereotaxic	 frame	(Kopf	 Instruments).	 A	midline	 skin	 incision	was	 performed	 to	 expose	 the	 skull	 bone.	Bregma	and	Lambda	were	used	as	anatomical	references.	As	Bregma	is	the	anatomical	intersection	between	the	sagittal	suture	and	the	coronal	suture,	Lamba	is	the	junction	of	the	 sagittal	 suture	with	 the	 lambdoid	 suture	 (fig.8).	 Correct	 animal	 positioning	 in	 the	frame	 and	 surgical	 coordinates	 were	 derived	 from	 these	 two	 anatomical	 references.	After	 delimitation	 of	 the	 targeted	 area	 for	 injection,	 a	 craniotomy	 was	 performed	through	 the	 left	parietal	 bone	or	 through	 the	occipital	 bone	 to	 access	 respectively	 the	forebrain	 and	 the	 cerebellum.	 All	 the	 coordinates	 were	 calculated	 based	 on	 an	anatomical	atlas	(Paxinos	and	Watson),	previously	piloted	in	previous	experiments	and	are	 shown	 in	 fig.9.	 For	 signaling	 activation	 in	 the	 CST,	 six	 injections	 sites	 were	performed	 in	 the	 left	 somatosensory	 cortex	 (fig.8).	 Injection	 sites	 were	 reached	vertically	with	a	glass	micropipette	and	injections	took	place	using	a	nanolitric	pump.	To	activate	 growth	 programs	 in	 the	 reticular	 formation,	 four	 virus	 injections	 were	performed	 at	 two	 different	 anteroposterior	 sites,	 with	 two	 distinct	 dorsoventral	coordinates.	 The	 ventral	 gigantocellular	 nucleus	 (vGI)	was	 reached	 vertically	 through	the	 cerebellum.	 Due	 to	 their	 fragility,	 glass	 micropipettes	 were	 replaced	 with	 a	 33G	Hamilton	syringe	for	vGI	injections.	For	each	site	in	both	the	motor	cortex	and	in	the	vGI,	250nl	of	viral	suspension	containing	all	three	virus	(1:1:1,	AAV2/9	IGF-1,	AAV2/9	OPN	and	 AAV2/9	 CNTF)	were	 injected	 using	 a	 nano-injector.	 Before	 careful	withdrawal	 of	the	 needle,	 2	 minutes	 were	 respected	 to	 avoid	 viral	 reflux.	 Following	 the	 same	
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procedure,	CST	and	RtST	were	labeled	with	300nl	of	10%	BDA	per	injection	site	in	the	motor	cortex	and	200nl	of	AAV5-TurboRFP	in	the	VGI.	After	completion	of	the	injections	skin	was	closed	using	non-resorbable	suture	(Ethilon	4.0).	
	
	
Fig.	8.	a)	Schematic	view	of	a	rat	bone	skull	showing	Bregma,	Lamba	and	the	skull	sutures.	b)	Anatomical	representation	of	
stereotaxic	 references.	 A	 craniotomy	window	 is	 depicted	 over	 the	motor	 cortex.	 c)	 Rat	 brain	 showing	 both	 craniotomies	
(dashed	rectangles)	in	the	left	parietal	bone	and	in	the	left	part	of	the	occipital	bone.	Green	dots	represent	the	cortical		and	
VGI	injections.1	
Fig.	9,	Stereotaxic	coordinates	used	for	the	D-14	virus	injections	as	well	as	the	D2	axons	tracing	injections	(BDA	and	AAV5-
RFP).	Bregma	was	used	as	reference	for	both	motor	cortex	and	VGI	injections.	Six	different	sites	were	targeted	in	the	motor	
cortex	with	a	dorsoventral	coordinate	located	-	1.45mm	from	the	brain	surface.	Two	injections	site	were	located	in	the	VGI	
with	two	different	dorsoventral	depths,	giving	total	of	four	injections.	The	injection	 rate	and	volume	were	conserved	for	all	
virus	injections.																																																									1	Skull’s	 schema:	 George	 Paxinos	 and	 Charles	Watson:	 The	 Rat	 Brain	 in	 Stereotaxic	 Coordinates,	 Academic	 Press,	 1998.	Brain’s	 picture:	 Hui-Feng	 Zhu	 et	 al.	 2010	 -	 International	 Journal	 of	 Biological	 Sciences	 -	 Catalpol	 Increases	 Brain	
Angiogenesis	and	Up-Regulates	VEGF	and	EPO	in	the	Rat	after	Permanent	Middle	Cerebral	Artery	Occlusion.			
Brain	region	
	
	
Referenc
e	point	
Antero-
posterior	(A/P)	
Medio-
lateral	(M/L)	
Dorso-
ventral	(D/V)	
Injection	volume	
Nanoliter	(nl)	
Injection	rate	
(nl/min)	Motor	cortex							
Bregma	(0,	0,	0)	 First	site:		-	0.5	mm	
Second	site:	-	0.5	mm	
Third	site:	-	1.5	mm	
Fourth	site:	-	1.5	mm	
Fifth	site:	-	2.5	mm	
Sixth	site:	-	2.5	mm		
	-	2	mm		-	3	mm		-	2	mm		-	3	mm		-	2	mm		-	3	mm		
	-	1.45	mm		-	1.45	mm		-	1.45	mm		-	1.45	mm		-	1.45	mm		-	1.45	mm	
	250	nl	each							
	200	nl/min											Ventral	gigantocellular	nucleus	(VGI)							
Bregma	(0,	0,	0)	 First	site:		-	11	mm	
Second	site:	-	11	mm	
Third	site:	-	12	mm	
Fourth	site:	-	12	mm		
	-	1	mm		-	1	mm		-	1	mm		-	1	mm	
	-	9	mm		-	8.8	mm		-	9	mm		-	8.8	mm		
	250	nl	each	 	200	nl/min	
		 				
Spine	surgery	Complete	 crush	 spinal	 cord	 injuries	were	 performed	 under	 complete	 anesthesia	with	isoflurane	and	Dorbene.	The	back	was	shaved	and	disinfected,	and	a	dorsal	midline	skin	incision	was	performed.	Muscles	were	carefully	detached	to	reach	the	thoracic	vertebra	column.	 A	 single	 T10	 laminectomy	was	 performed	 to	 expose	 the	 spinal	 cord,	 and	 the	dura	matter	was	kept	intact.	The	spinal	cord	was	then	crushed	laterally	with	n°2	forceps	at	 the	 spinal	 T10	 level.	 Compression	 was	 conducted	 laterally	 from	 both	 sides	 for	 5	seconds,	creating	a	transversally	complete	spinal	lesion.	In	order	to	label	the	injured	site	for	subsequent	intralesional	injections,	bilateral	injections	of	dark	dye	(100	nl	per	side)	were	performed	at	the	injured	level.	After	bleeding	control	was	achieved,	muscles	were	sutured	(Vicryl	5.0)	and	the	skin	was	closed	(Ethilon	4.0).	For	spinal	cord	growth	factor	depots,	a	similar	procedure	was	repeated	 to	reopen	the	 first	surgical	wound.	 Injection	sites	were	 reached	vertically	with	 a	 glass	micropipette.	DCH	hydrogel,	 either	 alone	or	loaded	with	cargo	molecules,	was	injected	1.1	ml	below	the	surface	of	the	spinal	cord	to	reach	centromedullary	layers.	
Histology	and	immunohistochemistry	At	 the	 end	 of	 experiments,	 animals	were	 deeply	 anesthetized	with	 an	 intraperitoneal	overdose	 of	 pentobarbital.	 Perfusion	 took	 place	 with	 4%	 paraformaldehyde	 (PFA)	delivered	 transcardially	 to	 the	 aorta.	 The	 central	 nervous	 system	was	 then	 dissected,	postfixed	 in	 4%	 PFA	 and	 saturated	 in	 30%	 sucrose.	 	 Spinal	 cord	 segments	 were	embedded	 and	 frozen	 in	 a	 cryoprotective	matrix.	 Using	 a	 Cryostat	microtome	 (Leica),	30μm-thick	 longitudinal	 sections	were	obtained	 from	 the	perilesional	 tissue,	mounted	on	 histologic	 slides.	 Rabbit	 anti-GFAP	was	 used	 as	 primary	 antibodies	 and	 Alexa-488	(green)	 as	 secondary	 antibodies.	 DAPI	 was	 used	 as	 nuclear	 non-specific	 maker.	Biotinylated	dextran	amines	(BDA)	were	reveled	with	biotin-avidin-peroxidase	complex	and	 diaminobenzidine	 as	 developing	 agent	 and	 revealed	 using	 a	 Cy5	 conjugated	 dye.	Bright-field	 and	 fluorescence	 microscopy	 (Zeiss)	 was	 used	 to	 examine	 and	 acquire	histologic	images	from	the	stained	sections.		Results	
Propriospinal	axon	regeneration	The	following	data	is	reported	from	the	work	of	Anderson	and	colleagues,	who	explored	the	requirements	of	propriospinal	axon	regeneration	(Anderson	et	al,	2018).	We	show	here	 RFP-traced	 propriospinal	 fibers	 after	 severe	 SCI	 in	 both	 treated	 and	 control	conditions	 (fig.10).	 We	 observe	 under	 10b	 a	 longitudinal	 spinal	 cord	 section	 from	 a	T10-injured	 rat	 that	 received	 successful	 regenerative	 interventions	 combining	 i)	AAV-[IGF1-CNTF-OPN]	 administered	 two	 segment	 rostral	 to	 the	 SCI	 two	 week	 before	 the	lesion,	ii)	remodeling	of	the	lesion	with	EGF-FGF	and	iii)	guidance	with	GDNF	provided	
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within	and	below	the	lesion	site.	The	descending	propriospinal	axons	were	traced	with	red	fluorescent	protein	(RFP),	appearing	in	red.		
	Astrocytes	were	 labeled	with	 an	 immunostaining	 against	 glial	 fibrillary	 acidic	 protein	(GFAP,	 green)	 that	 reliably	 delimits	 the	 non-neural	 lesion	 core.	 In	 addition	 all	 tissues	were	 conter-stained	 for	 DAPI	 (purple	 on	 the	 figure).	 Control	 animals	 (10a)	 only	received	a	complete	crush	SCI	followed	by	a	single	intralesional	injection	of	empty	DCH	vehicle	without	any	additional	factor.	GFAP-labeled	astrocytes	showed	that	the	SCI	was	anatomically	complete	across	the	entire	transverse	segment	of	the	spinal	cord	(10a,b,c),	with	 large	 lesion	 core	 (lc)	 in	 both	 control	 (10a)	 and	 treated	 animals	 (10b,c).	 RFP-tracing	demonstrates	satisfying	labeling	of	the	PrSp	in	both	the	control	and	the	treated	animal.	We	note	in	the	control	animal	(10a)	that	no	PrSp	axon	was	able	to	penetrate	the	non-neural	lesion	core.	In	addition	we	observe	the	presence	of	a	cystic	cavity	(cc),	which	appears	 attenuated	 after	 lesion	 remodeling	with	 EGF/FGF.	 In	 treated	 animals,	 robust	axon	regrowth	through	the	lesion	core	could	be	achieved	(10c),	that	successfully	reach	healthy	neural	tissue	beyond	the	lesion	(10d).	In	addition,	we	showed	that	less	axon	was	found	 at	 lesion	 center	 without	 propriospinal	 growth	 program	 activation	 and	 that	 no	more	 axon	were	 found	 at	 the	 lesion	 center	without	EGF-FGF	 remodeling	of	 the	 lesion	and/or	without	GDNF	guidance	cues	delivery,	demonstrating	that	all	three	components	of	 this	 regenerative	 intervention	 are	 individually	 necessary	 but	 sufficient	 only	 in	combination	 to	 promote	 robust	 propriospinal	 axons	 regrowth	 across	 complete	 SCI	 in	rodents.		
Corticospinal	axon	regeneration		We	 demonstrate	 here	 below	 (fig.11)	 a	 longitudinal	 spinal	 cord	 section	 from	 a	 T10-injured	rat	with	BDA-labelling	of	corticospinal	axons	after	complete	SCI.	The	candidate	procedure	 for	CST	axon	 regeneration	was	performed	as	 follows.	Animals	 received	 i)	 a	
		 				combined	injection	of	the	growth	modulating	AAV2/9-[IGF1-CNTF-OPN]	into	the	motor	cortex	 two	 weeks	 priori	 to	 the	 lesion,	 ii)	 remodeling	 of	 the	 SCI	 site	 using	 EGF-FGF	administered	 into	 the	 lesion	 core	 and	 iii)	 axon	 guidance	 with	 BDNF-GDNF-IGF1-NT3	delivered	within	and	caudally	to	the	lesion	site.		
	The	 descending	 corticospinal	 axons	 were	 labeled	 using	 biotinylated	 dextran	 amine	(BDA)	 revealed	 using	 a	 Cy5	 conjugated	 dye,	 appearing	 in	 turquoise	 blue	 on	 the	histologic	 acquisition	 (11a).	 The	 surrounding	 neural	 tissue	was	 highlighted	with	 glial	fibrillary	acidic	protein	(GFAP)	(11b)	showing	reactive	astrogliosis	bordering	the	non-neural	 lesion	 core	 (green).	 Astroglial	 immunostaining	 confirms	 that	 SCIs	 were	anatomically	 complete	 across	 the	 entire	 transverse	 section	 of	 the	 spinal	 cord	 (11a,c),	revealing	broad	lesion	cores	(lc).	BDA-staining	showed	satisfying	labeling	of	the	CST	on	the	rostral	part	of	the	spinal	cord.	However,	no	CST	axon	was	left	 in	the	vicinity	of	the	lesion	center.	Conversely,	 corticospinal	axons	dyed	back	and	degenerated	 towards	 the	cell	body	(11a,b).	This	extensive	CST	degeneration	could	be	explained	by	its	the	dorsal	localization	 making	 these	 fibers	 more	 susceptible	 to	 ischemic	 phenomenon.	 Another	hypothesis	 could	 be	 the	 different	 axonal	 survival	 program	 of	 CST	 neurons,	 rendering	CST	 less	 prone	 to	 plastic	 reorganization,	 as	 compared	 to	 other	 tracts.	 However,	 CST	regeneration	 associated	 with	 functional	 recovery	 after	 SCI	 was	 reported	 in	 both	 cell	transplantation	 approach	 (Kadoya	 et	 al.,	 2016)	 and	 intrinsic	 growth	 control	upregulation	(Y.	Liu	et	al.,	2017)	suggesting	that	CST	regeneration	is	feasible.				
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Reticulospinal	axon	regeneration	We	show	here	below	(fig.12)	RFP-traced	reticulospinal	axons	after	complete	SCI	under	both	 treated	 and	 control	 conditions.	 The	 histologic	 acquisitions	 (12b)	 depict	longitudinal	spinal	cord	sections	from	rats	following	complete	T10	crush	injury.	Animals	received	reticulospinal-adapted	regenerative	 interventions	with	 i)	 injection	of	AAV2/9	(IGF1-CNTF-OPN)	into	the	VGI	(reticular	formation)	two	weeks	before	the	lesion,	ii)	SCI	remodeling	 with	 EGF-FGF	 delivered	 to	 the	 lesion	 core,	 and	 iii)	 axon	 guidance	 using	BDNF-GDNF-IGF1-NT3	 administered	 within	 and	 caudally	 to	 the	 lesion	 site.	 The	descending	 reticulospinal	 axons	 were	 labeled	 with	 red	 fluorescent	 protein	 2	 (RFP-2,	red).	 Astrocytes	 were	 immunostained	 and	 revealed	 via	 glial	 fibrillary	 acidic	 protein	expression	(GFAP,	green).	For	comparison,	control	animals	(12a)	received	only	received	a	complete	crush	SCI,	followed	by	an	administration	of	empty	DCH	vehicle,	without	any	remodeling	 factor	 or	 guidance	 cue.	 No	 viral	 signaling-activation	 was	 performed	 in	control	animals.	
	GFAP-labeled	 astrocytes	 showed	 that	 the	 SCI	 was	 anatomically	 complete	 across	 the	entire	with	of	the	spinal	cord	(12a,b,c),	with	large	lesion	core	(lc)	 in	the	control	(12a)	and	 in	 the	 treated	animal	 (12b,c).	RFP2-staining	 shows	a	good	 labeling	of	 the	RtST	 in	both	 the	 control	 and	 the	 treated	 animal.	 In	 the	 control	 animal	 (12a)	 almost	 no	 RtST	axons	 reach	 the	 lesion	 center.	 In	 the	 treated	 animal	 some	 axons	 regrew	 through	 the	lesion	 core	 (12b,c)	 and	 reached	 the	 healthy	 tissue	 beyond	 the	 lesion	 into	 the	 caudal	healthy	tissue	(12d).	Some	cystic	cavities	(cc)	are	present	into	the	lesion	site	and	on	the	scar	 proximal	 border	 (12b,c).	 We	 demonstrated,	 that	 viral	 activation	 of	 (IGF1-CNTF-OPN)	 into	 the	 VGI	 (reticular	 formation),	 SCI	 remodeling	 with	 EGF-FGF	 and	 axon	guidance	 using	 BDNF-GDNF-IGF1-NT3	 allowed	 reticulospinal	 axon	 regrowth	 through	complete	SCI	and	that	some	fibers	successfully	reach	healthy	neural	 tissue	beyond	the	
		 				lesion	 (12d).	However,	 the	RtST	 regeneration	demonstrated	here,	 is	 less	 important	as	compared	 with	 the	 robust	 axon	 regeneration	 demonstrated	 in	 propriospinal	 system	(Anderson	 et	 al.,	 2018).	 We	 hypothesized	 that	 VGi	 viral	 activation	 with	 (IGF1-CNTF-OPN)	 may	 have	 cross-activated	 other	 signaling	 pathways,	 which	 should	 be	 identified	and	 more	 specifically	 targeted	 in	 order	 to	 optimize	 reticulospinal	 axons	 regrowth	strategy.			Discussion Severed	 axons	 fail	 to	 regrow	 spontaneously	 into	 complete	 spinal	 injuries	 in	 adult	mammals.	Recent	work	 -	 that	we	evoke	here	above	 -	demonstrated	 that	propriospinal	axons	 can	 robustly	 regrow	 across	 complete	 crush	 lesions,	 penetrate	 healthy	 caudal	circuits,	 form	 new	 synaptic-like	 contacts	 and	 conduct	 descending	 electrophysiological	input	past	 the	 lesion.	However,	propriospinal	axon	regeneration	 itself	does	not	 induce	improvement	of	motor	functions	(Anderson	et	al.	2018).	This	is	consistent	with	growing	evidence	that	new	projections	formed	after	complete	SCI	cannot	spontaneously	acquire	function	 but	 require	 active	 rehabilitation	 to	 support	 their	 integration	 into	 functional	neural	networks	 through	use-dependent	plasticity,	 that	was	demonstrated	 to	promote	functional	recovery	in	incomplete	models	of	SCI	(Asboth	et	al.,	2018;	van	den	Brand	et	al.,	 2012).	 In	 addition,	 recovery	might	 require	 extra	 descending	 tracts	 to	 relay	motor	commands,	 such	 as	 corticospinal	 and	 reticulospinal	 projections.	 Indeed	 it	 was	demonstrated	that	the	activation	of	IGF-1	and	OPN	led	to	robust	CST	regeneration	that	restored	CST-dependent	functions	after	spinal	cord	hemisection	(Y.	Liu	et	al.,	2017).	On	the	 other	 hand,	 reticulospinal	 projections	were	 shown	 to	 support	 functional	 recovery	after	 severe	 spinal	 cord	 contusion.	 Indeed	glutamatergic	 reticulospinal	 neurons	 in	 the	VGi	were	shown	to	relay	cortical	commands	downstream	and	enable	the	motor	cortex	to	regain	adaptive	control	over	paralyzed	legs	(Asboth	et	al.,	2018).	Depending	on	the	SCI	model,	CST	projections	recruit	either	RtST	or	PrSp	neuron	 to	bypass	 the	 lesion.	 In	 the	present	study,	we	precisely	explored	the	regenerative	potential	of	both	these	essential	tracts,	 known	 to	 be	 involved	 in	 the	 voluntary	 control	 of	 locomotion.	 We	 directly	transferred	the	successful	propriospinal-targeted	intervention	to	the	corticospinal	tract	and	to	the	reticulospinal	tract.	We	tested	whether	CST	and	RtST	axons	are	sensitive	to	neuronal	overexpression	of	the	factors	IGF1-CNTF-OPN,	associated	to	remodeling	of	the	lesion	 environment	using	EGF-FGF	 and	 chemo-attraction	using	NT3,	BDNF,	GDNF	and	IGF-1.	 Further,	 we	 assessed	 the	 possible	 formation	 of	 new	 axon	 bridges	 from	 long	descending	 tracts	 across	 complete	 spinal	 cord	 injury.	 Our	 results	 regarding	corticospinal	 axon	 regeneration	demonstrated	 that	our	 treatment	 failed	 to	 induce	any	axon	 regeneration.	 Conversely,	 the	 CST	 underwent	 strong	Wallerian	 degeneration,	 in	which	 axons	died	back	 towards	 their	 cell	 body.	Different	hypotheses	may	 explain	 this	extensive	CST	degeneration.	For	 instance,	 the	 severe	crush	model	of	 injury	performed	here,	might	cause	ischemic	phenomenon	against	which	CST	fibers	are	more	susceptible	
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because	of	their	dorsal	 localization.	Another	hypothesis	could	be	weaker	axon	survival	programs	 in	 CST	 neurons,	 rendering	 CST	 less	 prone	 to	 plastic	 reorganization,	 as	compared	 to	 other	 tracts.	 Further,	 the	 CST	 has	 been	 remaining	 refractory	 to	 most	therapeutic	 strategies	 attempted	 in	 the	 field	 of	 spinal	 repair	 for	 long	 (Tuszynski	 &	Steward,	2012).	More	recently,	robust	CST	axon	regeneration	associated	with	functional	recovery	was	reported	after	neural	progenitor	cells	transplantation	in	murine	model	of	SCI	(Kadoya	et	al.,	2016).	In	addition	it	was	demonstrated,	that	overexpressing	IGF1	and	OPN	 supported	 robust	 CST	 regrowth,	 together	 with	 recovery	 of	 CST-dependent	behavioral	 task	after	 incomplete	SCI	(Y.	Liu	et	al.,	2017).	As	CST	axons	regeneration	 is	feasible,	 it	 might	 be	 interesting	 to	 protect	 CST	 fibers	 from	 dieing	 back	 using	neuroprotective	approaches	before	trying	regenerating	them.	Our	goal	is	to	increase	the	direct	 descending	 motor	 commands	 through	 complete	 SCI	 either	 directly	 via	 CST	 or	indirectly	 via	RtST	 and	PrSp	 relays.	Given	 that	 die-back	 is	 less	 important	 in	 the	 latter	(RtST	 and	 PrSp),	 it	 highlights	 the	 importance	 of	 regenerating	 both	 these	 tracts.	 Our	results	 regarding	 reticulospinal	 axon	 regeneration	 demonstrated	 that	 some	 extent	 of	reticulospinal	axons	was	present	in	the	non-neural	lesion	core	and	beyond	the	injury	in	treated	 animals.	 In	 control	 animals,	 almost	 no	 RtST	 axons	were	 found,	 neither	 in	 the	lesion	nor	beyond	it.	These	results	strongly	suggest	that	the	RtST	was	responsive	to	our	treatment,	 and	 that	 IGF1-CNTF-OPN	 do	 enhance	 reticulospinal	 regeneration,	 even	though	the	density	of	regrown	axons	remained	very	limited.	Indeed,	as	compared	to	the	robust	propriospinal	regrowth	shown	in	previous	work	(see	above),	the	axonal	density	of	 regenerated	 RtST	 axons	 was	 negligible.	 This	 might	 be	 due	 to	 an	 inappropriate	combination	of	guidance	cues.	Further,	we	cannot	exclude	that	among	the	combination	of	 guidance	 cues,	 some	 are	 detrimental	 for	 reticulospinal	 axons	 regrowth.	 Indeed,	chemoattractant	 molecules	 for	 one	 axon	 tract	 may	 become	 repulsive	 for	 another.	Nevertheless,	 among	 our	 guidance	 cocktail	 there	 are	 some	 appropriate	 cues	 without	which	no	regeneration	could	occurs.	Lesion	remodeling	with	EGF-FGF	 induced	a	semi-permissive	environment	as	some	RtST	axons	were	found	in	the	lesion	core.	Both	lesion	remodeling	and	guidance	cues	promoted	suboptimal	RtST	regeneration,	and	could	thus	probably	 be	 refined	 to	 increase	 the	 regenerative	 potential.	 Furthermore,	 intrinsic	growth	 programs	 vary	 between	 neuron	 subtypes	 (He	 &	 Jin,	 2016),	 so	 that	 a	 strategy	working	 in	 the	 propriospinal	 system	 will	 not	 necessarily	 work	 for	 reticulospinal	neurons.	Thus	identifying	the	specific	molecular	profile	of	each	pathway	will	be	required	to	 maximize	 our	 regrowth	 effect.	 The	 activation	 of	 IGF1-CNTF-OPN	 is	 known	 to	 co-activate	 different	 regenerative	 pathways,	 such	 as	mTOR	 and	 STAT3	 (Bei	 et	 al.,	 2016;	Duan	 et	 al.,	 2015;	 Y.	 Liu	 et	 al.,	 2017).	We	 hypothesized	 that	 vGI	 viral	 activation	with	[IGF1-CNTF-OPN]	may	have	cross-activated	other	signaling	pathways,	which	should	be	identified	 and	 more	 specifically	 targeted	 in	 order	 to	 optimize	 reticulospinal	 axon	regrowth	 strategy.	 We	 should	 perform	 RNA	 sequencing	 of	 brainstem	 during	development	to	understands	mechanisms	of	axogenesis	in	brainstem-spinal	neurons	as	well	 as	 during	 neurorehabilitation	 to	 understand	 intracellular	 mechanisms	 of	reticulospinal	 reorganization.	 Regarding	 functional	 aspects,	 we	 did	 not	 expect	 any	functional	 recovery	 based	 on	 axon	 regrowth	 alone.	 Indeed,	 as	 previously	 explained,	
		 				functional	 recovery	 would	 certainly	 require	 activity-based	 neurorehabilitation	 to	integrate	 the	 news	 fibers	 into	 functional	 networks.	 Further	 perspectives	 would	 be	 to	combine	 such	 strategies	 with	 propriospinal	 regeneration	 and	 neuroprosthetic	rehabilitation	 to	 increase	 our	 chances	 to	 restore	 functional	 motor	 command	 after	complete	SCI.	 In	addition,	we	keep	 in	mind	that	somatosensory	 feedback	 to	 the	cortex	should	be	addressed.			Conclusion	/	Perspectives	of	the	study To	 this	 date,	 rehabilitating	 complete	 spinal	 cord	 injuries	 remains	 a	 challenge.	Neuroprosthetic	rehabilitation	demonstrated	that	significant	functional	benefit	could	be	achieved	through	lumbar	electrochemical	neuromodulation	in	both	human	patients	and	animal	models	after	 incomplete	SCI.	However,	 following	complete	SCI,	neuroprosthetic	rehabilitation	still	 fails	 to	yield	any	 functional	benefit.	Growing	evidence	put	 into	 light	the	pivotal	 role	of	both	propriospinal	and	reticulospinal	 tracts	 in	 relaying	 information	around	 incomplete	 SCIs.	 In	 order	 to	 transfer	 such	 relay	 reorganization	 in	 complete	models	 of	 SCI,	 intrinsic	mechanisms	 of	 axon	 regeneration	 failure	 have	 been	 explored	and	 successfully	 reversed.	 Indeed,	 propriospinal	 axons	 do	 regrow	 and	 build	 a	 robust	descending	 bridge	 across	 complete	 SCIs	 when	 the	 required	 growth	 facilitators	 are	provided.	However,	 this	 robust	propriospinal	 bridging	 still	 fails	 to	promote	 functional	recovery	by	itself.	We	hypothesize	that	regrown	propriospinal	axons	may	transfer	only	an	 insufficient	 fraction	 of	 the	 descending	motor	 input,	 and	 therefore	 do	not	 suffice	 to	restore	 voluntary	 hindlimb	 movements.	 In	 incomplete	 models,	 motor	 commands	 are	relayed	 either	 by	 reticulospinal,	 or	 by	 propriospinal	 neurons.	 Inducing	 reticulospinal	regeneration	across	complete	SCI	may	increase	the	fraction	of	motor	control	transferred	to	lumbosacral	circuits,	when	combined	to	propriospinal	regrowth	after	complete	SCI.	In	parallel	 and	 based	 on	 previous	work,	 promoting	 direct	 regrowth	 of	 CST	 axons	 across	complete	 lesions	would	contribute	 to	bring	direct	and	non-relayed	motor	control	past	injuries.	We	 assessed	 the	 feasibility	 of	 RtST	 and	 CST	 regeneration	 based	 on	 previous	successful	 regeneration	paradigms	and	demonstrated	 that	RtST	axon	 regrowth	 can	be	achieved	but	needs	to	be	optimized,	whereas	CST	neurons	were	not	responsive	 to	our	regrowth	 strategy.	 In	 our	 approach,	 the	 specific	 activation	 of	 axonal	 growth-related	genes	associated	with	specific	growth	and	guidance	factors	enables	precise	tuning	of	the	administered	 components,	 in	 order	 to	 promote	 better	 understanding	 of	 the	 necessity	and	efficiency	of	 each	 component.	Mechanistic	 approaches	are	 a	paradigm	shift	 in	 the	field	of	spinal	cord	regeneration,	so	that	targeted	and	incrementally-built	therapies	are	currently	replacing	empirical	constructs.	A	coming	challenge	will	be	to	identify	specific	cues	 for	 each	 neuronal	 subtype,	 in	 order	 to	 enable	 multi-tract	 regeneration	 across	severe	 spinal	 cord	 injuries.	 But	 regrowth	 itself	 may	 not	 be	 sufficient	 to	 promote	functional	 recovery.	 Indeed,	axons	need	 to	establish	coherent	synaptic	contacts	within	the	healthy	structures	 located	below	 the	 lesion	 in	order	 to	 induce	behavioral	benefits.	
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Our	 data	 confirms	 and	 provides	 crucial	 information	 for	 the	 development	 of	 future	regenerative	 therapies.	However,	 combinatorial	 strategies	will	need	 to	be	designed,	 in	order	 to	 address	 multi-disciplinary	 solutions	 to	 the	 very	 complex	 spinal	 cord	 injury	challenge.		Bibliography		
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